90311854 - RAKUTEN MEDICAL

Information

• Trademark
• 90311854

• Source

• Serial Number

  90311854

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 35 - Advertising
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  November 11, 2020
  4 years ago

• Transaction Date

  March 19, 2025
  21 days ago

• Status Date

  December 13, 2024
  3 months ago

• Published for Opposition Date

  June 15, 2021
  3 years ago

• Location Date

  December 13, 2024
  3 months ago

• First Use Anywhere Date

  April 26, 2024
  11 months ago

• First Use In Commerce Date

  April 26, 2024
  11 months ago

• Status Code

  814

• Current Location

  TMEG LAW OFFICE 101

  Employee Name

  IN, SUNG

• Attorney Docket Number

  1Y0049.00286

  Attorney Name

  Anna Kurian Shaw

  Law Office Assigned Location Code

  L30

• Owners

  • RAKUTEN, INC

Case File Statements

• GS0411: Educational services, providing training in the field of medicines, medical devices, pharmaceuticals, clinical trials and health care; Teaching and training services, namely, courses, classes, lessons and seminars in the field of medicines, pharmaceuticals and health care; Arranging, conducting and organization of congresses, conferences, conventions and symposiums in the field of medicines, pharmaceuticals and health care; Educational services, namely, providing classes, seminars, and lectures, all in the field of the diagnosis and treatment of cancer; education in the nature of classes, seminars, and training in the oncology field
• GS0051: Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for the treatment of cancer; Cancer treatment agent in the nature of pharmaceutical preparations; Pharmaceutical drugs for cancer treatment; Diagnostic agent used for cancer; Pharmaceutical preparations for the treatment and prevention of autoimmunological disorders and diseases, bacterial disorders and diseases, cardiovascular disorders and diseases, central and peripheral nervous system disorders and diseases, diabetic disorders and diseases, endocrine disorders and diseases, haematological disorders and diseases, hormonal disorders and diseases, gastrointestinal disorders and diseases, gout, immunological disorders and diseases, infectious disorders and diseases, inflammation and inflammatory disorders and diseases, musculoskeletal disorders and diseases, neurological disorders and diseases, oncological disorders and diseases, pain, respiratory disorders and diseases, urological and viral disorders and diseases; Medical preparations for the treatment and prevention of autoimmunological disorders and diseases, bacterial disorders and diseases, cardiovascular disorders and diseases, central and peripheral nervous system disorders and diseases, diabetic disorders and diseases, endocrine disorders and diseases, haematological disorders and diseases, hormonal disorders and diseases, gastrointestinal disorders and diseases, gout, immunological disorders and diseases, infectious disorders and diseases, inflammation and inflammatory disorders and diseases, musculoskeletal disorders and diseases, neurological disorders and diseases, oncological disorders and diseases, pain, respiratory disorders and diseases, urological and viral disorders and diseases; Diagnostic preparations for medical purposes
• GS0351: Compilation of statistical data relating to medical research for business purposes
• GS0441: Medical services; Medical information; Providing medical information from a web site; Medical testing for diagnostic or treatment purposes; Medical treatment services; Medical care services; Medical analysis services relating to the treatment of persons provided by a medical laboratory; Medical services in the field of oncology; Medical consultation; Medical advisory services; Compilation of medical reports, namely, medical reporting services; Issuing of medical reports, namely, medical reporting services; Medical and healthcare clinics; Medical assistance; Healthcare services; Rental of medical machines and apparatus; Consultancy and information services relating to the diagnostic, prophylactic, and therapeutic properties of medical products; Providing information in the field of health care, medical conditions, medicine and pharmaceuticals; Providing medical information on pharmaceuticals and oncology platforms; Providing medical and patient support information in relation to the treatment of cancer; Counselling services, namely, medical counselling for patients diagnosed with cancer; Information services in the field of diagnosing and treating cancer; Providing online information services, namely, prescription drug information regarding diagnostic, prophylactic, and therapeutic properties; Providing information in the field of medicine; Providing medical information regarding medical conditions and diseases and providing information relating to the health effects of pharmaceuticals; Providing information and content about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival via a website; Providing information about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival via an online searchable database; Medical diagnostic testing and reporting services; Genetic testing for diagnostic and treatment purposes; Providing healthcare information regarding cancer drugs and cancer treatment; Maintaining personal medical history records and files
• DS0000: "MEDICAL"
• GS0101: Medical devices, apparatus and instruments for detecting and treating cancer, namely, lasers for medical use, lasers for medical purposes, lasers for medical use; Dental devices, apparatus and instruments for detecting and treating cancer namely, lasers for dental use, lasers for dental purposes, lasers for dental use
• GS0421: Testing and research on medical treatment methods and techniques; Provision of medical and scientific research information on clinical trials; Research and development in the field of immunology; Testing and research on pharmaceuticals; Medical and pharmacological research services and clinical trials for others; Research, development, and consultation related thereto in the field of medicine; Providing medical and scientific research information in the field of pharmaceuticals; Pharmaceutical drug development services; Medical laboratories; Design and development of medical technology; Scientific, biological and medical research; Conducting clinical trials for others

Case File Event Statements

• 11/14/2020 - 4 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 1/11/2021 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/14/2021 - 3 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 4/23/2021 - 3 years ago

  4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 4/23/2021 - 3 years ago

  5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 4/23/2021 - 3 years ago

  6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 4/23/2021 - 3 years ago

  7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 4/23/2021 - 3 years ago

  8 - SUSPENSION LETTER WRITTEN Type: CNSL

• 4/23/2021 - 3 years ago

  9 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 4/23/2021 - 3 years ago

  10 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 5/5/2021 - 3 years ago

  11 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 5/10/2021 - 3 years ago

  12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/26/2021 - 3 years ago

  13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 6/15/2021 - 3 years ago

  14 - PUBLISHED FOR OPPOSITION Type: PUBO

• 6/15/2021 - 3 years ago

  15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/24/2021 - 3 years ago

  16 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA

• 7/19/2021 - 3 years ago

  17 - ASSIGNED TO PETITION STAFF Type: APET

• 7/20/2021 - 3 years ago

  18 - POST PUBLICATION AMENDMENT - ENTERED Type: CHPB

• 8/10/2021 - 3 years ago

  19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 1/20/2022 - 3 years ago

  20 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 1/20/2022 - 3 years ago

  21 - SOU EXTENSION 1 FILED Type: EXT1

• 1/20/2022 - 3 years ago

  22 - SOU EXTENSION 1 GRANTED Type: EX1G

• 1/22/2022 - 3 years ago

  23 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 8/5/2022 - 2 years ago

  24 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 8/5/2022 - 2 years ago

  25 - SOU EXTENSION 2 FILED Type: EXT2

• 8/5/2022 - 2 years ago

  26 - SOU EXTENSION 2 GRANTED Type: EX2G

• 8/9/2022 - 2 years ago

  27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 1/23/2023 - 2 years ago

  28 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 1/23/2023 - 2 years ago

  29 - SOU EXTENSION 3 FILED Type: EXT3

• 1/23/2023 - 2 years ago

  30 - SOU EXTENSION 3 GRANTED Type: EX3G

• 1/25/2023 - 2 years ago

  31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 8/8/2023 - a year ago

  32 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 8/8/2023 - a year ago

  33 - SOU EXTENSION 4 FILED Type: EXT4

• 8/8/2023 - a year ago

  34 - SOU EXTENSION 4 GRANTED Type: EX4G

• 8/10/2023 - a year ago

  35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 10/26/2023 - a year ago

  36 - ASSIGNED TO EXAMINER Type: DOCK

• 2/5/2024 - a year ago

  37 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 2/5/2024 - a year ago

  39 - SOU EXTENSION 5 FILED Type: EXT5

• 2/21/2024 - a year ago

  38 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 2/21/2024 - a year ago

  40 - SOU EXTENSION 5 GRANTED Type: EX5G

• 2/22/2024 - a year ago

  41 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 8/5/2024 - 8 months ago

  43 - USE AMENDMENT FILED Type: IUAF

• 8/5/2024 - 8 months ago

  42 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 8/7/2024 - 8 months ago

  44 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 9/9/2024 - 7 months ago

  47 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/9/2024 - 7 months ago

  45 - SU - NON-FINAL ACTION - WRITTEN Type: CNRT

• 11/14/2024 - 4 months ago

  49 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 11/14/2024 - 4 months ago

  48 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD

• 12/13/2024 - 3 months ago

  52 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/13/2024 - 3 months ago

  51 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/14/2024 - 3 months ago

  50 - ASSIGNED TO LIE Type: ALIE

• 9/9/2024 - 7 months ago

  46 - NON-FINAL ACTION E-MAILED Type: GNRT